E68-77947-65367
1 vaccination
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 430 / OH
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Moderna
-
2021-03-13
Survey response — day 0, dose 1MedDRA: Dizziness, Hyperhidrosis, Immediate post-injection reaction — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Significant dizziness, light headedness, and sweating five minutes after receiving the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-03-14
- 2021-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Significant dizziness, light headedness, and sweating five minutes after receiving the vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release